News tagged with tyrosine kinase inhibitors

Related topics: patients · lung cancer · mutations

Cola intake increases exposure of erlotinib

(HealthDay)—Cola intake leads to a clinically relevant and statistically significant increase in the bioavailability of erlotinib during esomeprazole treatment, according to a study published online Feb. 8 in the Journal ...

Feb 10, 2016
popularity1 comments 0

Subscribe to rss feed